Think of Verquvo as a "Niche" Med for Heart Failure
You'll hear once-daily vericiguat (Verquvo) is a new add-on for worsening heart failure with reduced ejection fraction (HFrEF).
Vericiguat is the first "soluble guanylate cyclase stimulator" for HFrEF. It relaxes blood vessels through the nitric oxide pathway.
Most evidence is in patients already on triple therapy...an ACEI, ARB, or sacubitril/valsartan (Entresto), beta-blocker (carvedilol, etc), AND aldosterone antagonist (spironolactone, etc).